Eric Johnson

Eric Johnson has worked in the life sciences industry since 2008. Starting with Iverson Genetic Diagnostics, they held the role of Interim Chief Scientific Officer and Clinical Director. In 2010, they moved to Transgenomic, Inc. and served as Medical Director for Laboratory Services. In 2012, Johnson returned to Iverson Genetic Diagnostics as Consulting Laboratory Director and New York CLEP compliant Lab Director. In 2013, they took on the role of Laboratory Director at Parabase Genomics. In 2016, they began working at Phi Life Sciences as Laboratory Director/Technical Supervisor/Consultant and NY CLEP Director. In 2017, they joined Advanced Clinical Laboratory Solutions, Inc. (ACLS) as Laboratory Director. In 2018, they became Compliance Officer at EnMed MicroAnalytics. In 2019, they were appointed Director Of Laboratory Services at miR Scientific, LLC. Finally, in 2021, Johnson assumed the role of Laboratory Director/CSO at Quadrant Biosciences Inc.

Eric Johnson attended the University of Pennsylvania from 1982 to 1988 and obtained a Ph.D. in Pharmacology/Neuroscience.